GP
DFTX

Guardian Partners’s Definium Therapeutics DFTX Stock Holding History

Guardian Partners’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.1K Buy
+66
New +$1.63K ﹤0.01% 369

Other funds holding DFTX

AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
PFA
Peak Financial Advisors Denver, Colorado $242M AUM 19.63% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
KWA
Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return

Guardian Partners's DFTX Position: Q2 2026 in Review

Guardian Partners opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 66 shares worth $3.1K. The stake represents ﹤0.01% of the portfolio and ranks #369 among its holdings.

69 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Guardian Partners held 66 shares of Definium Therapeutics worth $3.1K as of Q2 2026.
  • Definium Therapeutics was a new Guardian Partners position in Q2 2026.
  • Definium Therapeutics made up ﹤0.01% of Guardian Partners's portfolio in Q2 2026, its #369 holding.
  • 69 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Guardian Partners's 13F filing for Q2 2026, filed 29 Jul 2026.